Health Canada drug identification number

DIN 02489783 — ZEJULA 100 MG

ZEJULA is a capsule of Niraparib marketed by GLAXOSMITHKLINE INC. The full Niraparib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02489783
Brand name
ZEJULA
Active ingredient
Niraparib
Strength
100 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
GLAXOSMITHKLINE INC
Health Canada status
DORMANT
Drug class
Poly (ADP-ribose) polymerase (PARP) inhibitor (antineoplastic agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Niraparib products

DINBrandStrengthFormManufacturerStatus
02530031 ZEJULA 100 MG TABLET GLAXOSMITHKLINE INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.